Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
About the Study The approval of Apidra (R) for pediatric use is based upon a 26-week, phase III, open-label, active control study of Apidra (R) in comparison with insulin lispro in 572 children and ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
BRIDGEWATER, N.J. A combination treatment of the insulins Lantus and Apidra, by Sanofi-aventis, at mealtime showed a significant reduction in post meal blood glucose and A1C levels, when using two ...
Verywell Health on MSN
How to Lower Your Blood Sugar Quickly
Medically reviewed by Danielle Weiss, MD Key Takeaways Taking rapid-acting insulin is the fastest way to lower high blood ...
Sanofi-aventis has received approval for Apidra (insulinglulisine [rDNA origin] injection) to improve glycemic control in children agedfour years and older with diabetes mellitus. The clearance for ...
Oct. 5, 2004 — The European Commission has approved for use in the European Union an expanded dosing indication for darbepoetin alfa, etanercept for moderate to severe plaque psoriasis, insulin ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients and health care professionals can expect a ...
The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback